← All themes

Radiopharmaceutical & Imaging Probes

Compounds, often featuring metal chelators or specific labeling moieties, designed for use in medical imaging techniques like Positron Emission Tomography (PET) or for radionuclide therapy, enabling diagnostic visualization or targeted radiation treatment.

5,609 US filings from 2,134 companies since 2023 · 2023: 1,324 · 2024: 1,846 · 2025: 1,753 · 2026 YTD: 686

Acyclic / Cyclic Compounds (Other Elements)

Top companies

Ranked by filings in this theme since 2023. 2026 is partial.